Capital Counsel’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
BBHC
IC
Capital Counsel's NVS Position: Q4 2015 in Review
Capital Counsel sold out of Novartis (NVS) in Q4 2015, closing a stake of 3,007 shares — an estimated $248K sold.
Capital Counsel first reported a position in NVS in Q1 2015 and held it in 3 quarters. The position peaked at $248K in Q3 2015. 926 funds tracked by Wall St. Rank hold NVS as of Q4 2015.
- Capital Counsel reported no remaining Novartis position as of Q4 2015 after selling out during the quarter.
- Capital Counsel sold 3,007 Novartis shares in Q4 2015, an estimated $248K.
- Capital Counsel first reported a position in Novartis in Q1 2015 and held it in 3 quarters.
- Capital Counsel's Novartis position peaked at $248K in Q3 2015.
- 926 funds tracked by Wall St. Rank held Novartis as of Q4 2015.
Based on Capital Counsel's 13F filing for Q4 2015, filed 11 Feb 2016.